Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elio Scarpini

Showing results (1-10 of 329) with videos related to

Pageof 33
Sort By:
Expert Opinion on Investigational Drugs|May 30, 2015
Idalopirdine as a treatment for Alzheimer's diseaseDaniela Galimberti, Elio Scarpini
Frontiers in Bioscience (Scholar Edition)|January 4, 2011
Inflammation and oxidative damage in Alzheimer's disease: friend or foe?Daniela Galimberti, Elio Scarpini
Journal of Neural Transmission (Vienna, Austria : 1996)|April 25, 2012
Clinical phenotypes and genetic biomarkers of FTLDDaniela Galimberti, Elio Scarpini
Expert Review of Neurotherapeutics|October 9, 2009
Alzheimer's disease: from molecular pathogenesis to innovative therapiesElio Scarpini, Filippo Cogiamanian
Expert Opinion on Investigational Drugs|November 26, 2016
Pioglitazone for the treatment of Alzheimer's diseaseDaniela Galimberti, Elio Scarpini
Therapeutic Advances in Neurological Disorders|July 19, 2011
Disease-modifying treatments for Alzheimer's diseaseDaniela Galimberti, Elio Scarpini
International Journal of Clinical and Experimental Medicine|July 8, 2010
Genetics and biology of Alzheimer's disease and frontotemporal lobar degenerationDaniela Galimberti, Elio Scarpini
Journal of Neurology|June 23, 2012
Progress in multiple sclerosis research in the last yearDaniela Galimberti, Elio Scarpini
Current Aging Science|March 20, 2010
Treatment of Alzheimer's disease: symptomatic and disease-modifying approachesDaniela Galimberti, Elio Scarpini
Frontiers in Neurology|April 27, 2012
Genetics of frontotemporal lobar degenerationDaniela Galimberti, Elio Scarpini
Pageof 33

Showing results (1-10 of 329) with videos related to

Sort By:
Pageof 33
Expert Opinion on Investigational Drugs|May 30, 2015
Idalopirdine as a treatment for Alzheimer's diseaseDaniela Galimberti, Elio Scarpini
Frontiers in Bioscience (Scholar Edition)|January 4, 2011
Inflammation and oxidative damage in Alzheimer's disease: friend or foe?Daniela Galimberti, Elio Scarpini
Journal of Neural Transmission (Vienna, Austria : 1996)|April 25, 2012
Clinical phenotypes and genetic biomarkers of FTLDDaniela Galimberti, Elio Scarpini
Expert Review of Neurotherapeutics|October 9, 2009
Alzheimer's disease: from molecular pathogenesis to innovative therapiesElio Scarpini, Filippo Cogiamanian
Expert Opinion on Investigational Drugs|November 26, 2016
Pioglitazone for the treatment of Alzheimer's diseaseDaniela Galimberti, Elio Scarpini
Therapeutic Advances in Neurological Disorders|July 19, 2011
Disease-modifying treatments for Alzheimer's diseaseDaniela Galimberti, Elio Scarpini
International Journal of Clinical and Experimental Medicine|July 8, 2010
Genetics and biology of Alzheimer's disease and frontotemporal lobar degenerationDaniela Galimberti, Elio Scarpini
Journal of Neurology|June 23, 2012
Progress in multiple sclerosis research in the last yearDaniela Galimberti, Elio Scarpini
Current Aging Science|March 20, 2010
Treatment of Alzheimer's disease: symptomatic and disease-modifying approachesDaniela Galimberti, Elio Scarpini
Frontiers in Neurology|April 27, 2012
Genetics of frontotemporal lobar degenerationDaniela Galimberti, Elio Scarpini
Pageof 33